Bio-AMD Inc. (fka BIAD)

[croptop]

Yea, LOL To Da China moon!!!
China really, I think I would of left that out....
Huge volume :-0

[jaytea]

TO DA MOON!

[croptop]

State Intellectual Property Office of the PRC

China patent? HAHAH

Like they are regulated???

Maybe a counterfeit? LOL

[croptop]

DARESBURY, ENGLAND / ACCESSWIRE / January 11, 2016 / Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company" OTCQB: BIAD) is pleased to provide an update on progress for shareholders.

We believe our strategy and approach of engagement with highly capable global partners to efficiently develop our technologies and take them robustly to market should create significant value, certainly compared to the Company's prevailing market capitalisation.

The Company understands shareholder frustration with a lack of regular and detailed news about our technologies. This is largely due to confidentiality obligations and restrictions imposed on med-tech companies by larger partners.

The Company is, however, delighted with its progress and accepts these temporary restrictions as commercial reality. It is committed to updating shareholders as far as it can. It looks forward to announcing developments as restrictions are lifted.

The Company can update as to the following:

First MIDS patent grant

The Company has been informed by its patent attorney that a patent application made in the People's Republic of China ("PRC") for our Magnetic Immunoassay Detection System (MIDS) technology is to be granted, subject to routine administration matters. A further announcement will be made when the official grant is confirmed by the State Intellectual Property Office of the PRC.

The Company is delighted to have likely obtained this first protection for its MIDS technology platform. Accordingly, the Company expects to receive similar MIDS patent grants in due course as a result of applications already made in other territories; in the U.K. and in more than 145 Contracting States under the international Patent Cooperation Treaty, and separately in the U.S.A., European Union and India.

MIDS is an early stage technology with significant potential for the Point of Care sector, offering gold standard, laboratory accuracy over a wide range of tests. Subject to resources being available, the Company plans to produce a MIDS technology bench demonstrator this year.

This is expected to be the second patent grant relating to our IP (the first covering our COAG platform), which we believe confirms our ability to create unique and novel technologies.

Patient blood testing

We will soon complete our patient blood testing and analysis program at the Wythenshawe Hospital, part of the University Hospital of South Manchester NHS Foundation Trust. These results are applicable to our development work. We continue to work with our partners, hospitals and R&D institutions on this and expect to continue and expand our productive relationships with them.

Diagnostics as a service using DSR

Very recently the Company entered into preliminary discussions with a potential partner to offer a disposable device for common STD tests linked to voluntary screening provided by the UK National Health Service ("NHS").

The Company believes that the application of its DSR platform combined with the potential partner's control technology, already in use by the NHS, will add major value to the NHS national screening program through enhanced screening uptake, faster result notification and targeted care plan implementation including personal support.

[croptop]

Bio-AMD, Inc.: First MIDS Patent Grant Likely, Shareholder UpdateSpoke

25 minutes too soon....LMAO

[croptop]

What how longer "shortly" is, same as "SOON"? LOL

Tom Barr <[e-mail]>

Jan 4 at 11:10 AM

We have spoken to Ben Padnos at length under NDA to see how he might assist the Company (as we would any shareholder) and are separately expecting to put out an update on where we are, shortly.

Regards

Tom

[PatrickBateman]

Getting the feeling this is just another OTC scam

[nsomniyak]

Yeah - not much happening

[croptop]

Hi
Not many buying down here is there?
Seems many were trying at .10

[nsomniyak]

I got a tiny little partial fill on my buy order at .076 today

[croptop]

And there it is .07......
guess tha NDA is NDA, LOL
Maybe that guy can write an SA and make a hint...LMAO
2k volume, a joke, like china

[jaytea]

As you will note, I was not referring to BIAD or to any specific post on this or any other board, but just noting the general trend among ihub posters. The only reason any stock ever goes down, it would appear, is because of greedy shorts or nefarious MM's.
Best of luck to you.
And Go BIAD!

[derkampfer]

No. That was me. Long. Not short. Added 20K shares today. 25K days ago. Once we get update from management stock will rise. Fear leaves. BIAD has great things happening. Just quiet. Unfortunately. Need update. Highly highly undervalued. $3.95M market cap nonsensical.

But good buying opp here in mid .08s.

GLTA

[croptop]

LOL, understood!!! Need a laugh once in awhile

[jaytea]

Whenever a stock goes down, someone on ihub blames it on manipulation by shorts and MM's.
figured it was worth a try here. : )

[croptop]

LOL, come on jay
Shorts, really?

Short Interest

No short interest available.

Float
41.0M
Shares Outstanding
46.0M
Institutions Holding Shares
1
% Held by Institutions
0.24%

No insider trading activity.

Company Officers

David S. MillerPres.
Thomas BarrCEO
Robert GalvinCFO

Address

3Rd Floor, 14 South Molton Street
London, W1K 5QP
United Kingdom
Phone: [phone]
http://www.bioamd.com

[jaytea]

$BIAD!
Chart looks primed for the next big run!
Shorts will burn when the MM's decide to let this one rip!
IMO!

[croptop]

.12. .10, .09....
.06 soon?

[croptop]

got this from someone.....

Dear Mr. XXXX



We have spoken to Ben Padnos at length under NDA to see how he might assist the Company (as we would any shareholder) and are separately expecting to put out an update on where we are, shortly.



Regards



Tom

[jaytea]

I'm gonna bet ... nuthin

[croptop]

sent an email to CEO...Lets see what comes from it...

[PatrickBateman]

Yawn

[thought013]

Happy new year to you as well Croptop! Would also love to see the mgmt give us more frequent updates, but do believe 2016 will bring something good for us. Still long.

[croptop]

Deaf ears for sure......
Don't have to disclose anything, just tell shareholders
happy new year, nothing to report currently!! LOL
Hate when shareholders don't get a word from management...whats this, almost a year?
Thats just not right!!Lets hope for a good 2016..

[BlockTrade]

Added 31k additional shares @ 0.08........

[BlockTrade]

Not impressed with managements transparency with its shareholders at this point, but do believe BIAD shares are under valued and will be worth much more some day........When is that day?

[jaytea]

And I salute you, sir.
You are a solid American.
GLTY.

[BlockTrade]

Just added 22,900 BIAD @ 0.0853........

[JJSeabrook]

Evidently the letter fell on deaf ears. LOL

[jaytea]

and down we go.
absolutely no reason for anyone to want to buy this turd-ball at this point.

[croptop]

I do not know value, wasn't here last year...I do not see a last YR letter..

[value1008]

In any case there should be the usual yearly letter to shareholders within a few weeks, no?

[croptop]

Maybe there will be an update (answer) to the letter...

[JJSeabrook]

Hopefully it will motivate them to release SOMETHING to their shareholders.

[bar1080]

Oh ok. GL

[croptop]

It does look like that, but i get the SEC filings right next to the stock symbol if I make that board a "follow"...The filings show right up on IHUB. I was wondering that cause I have gotten several inquiries from ihub members wondering where i got that, and its right next to symbol BIAD, or any board I follow...

[bar1080]

Well it showed today's date at the top so I thought it was something you had just written.

[croptop]

Me? Naw....I am a tennessee Hick ridge runner...up in the smokies
That letter was in the recent filings, a 13k i think

I could not write that elegant, nor spell...LOL

[bar1080]

Croptop, are you Benjamin L. Padnos?

[croptop]

Lets see what this letter does....

December 15, 2015


Mr. Tom Barr, CEO
Bio-AMD, Inc.
Daresbury Innovation Centre
Keckwick Lane
Daresbury, Cheshire WA4 4FS
Email: [e-mail]

Subject: Transparency, Shareholder Value and Board of Directors Composition


Dear Tom,

As you are aware, I am one of the largest individual shareholders of Bio-AMD, Inc., with current ownership of 1,031,000 shares, or approximately 2.24% of the 45,975,966 shares outstanding as of November 6, 2015, according to company's Q3 filing with the SEC. Furthermore, I have numerous friends and business colleagues who collectively own millions and millions of additional shares.

I began building my position in August 2012. At that time, with the stock trading around $.07, I was buying BIAD shares for essentially the value of the cash in the bank, despite the company owning an interesting intellectual property portfolio and having multiple products in development. The company was primarily developing its Digital Strip Reader (DSR) technology and looking to apply it into the over-the-counter ("OTC") digital pregnancy testing market. Bio-AMD's other focus was development of a hand-held monitoring device for blood coagulation (COAG). The company's Master Agreement with Sysmex Corporation, announced last December, was an exciting milestone toward the commercialization of our COAG technology. I am also optimistic about the opportunities with Bio-AMD's Magnetic Immunoassay Detection System ("MIDS") technology.

Over the years, we have had numerous discussions about the importance of communicating with investors and offering as much visibility and transparency as possible into what's going on with advancements in the technology and intellectual property development, on the business development front, and across other areas of the company. I certainly understand and respect the fact that you are limited in what you can say regarding certain aspects of the business and that some current and/or prospective partners demand confidentiality. But as a publicly-traded company, it is essential to find a middle-ground.

I have been hands-off and extremely accommodating for more than three years and given you and your colleagues plenty of time to deliver operating performance without distractions. Unfortunately, BIAD stock continues to underperform and its shares are largely ignored. The average daily volume over the past six months is about 34,000 shares, or ~$4,200/day. I and my fellow shareholders have not been rewarded for our patience, and as I am the recipient of numerous calls and emails from frustrated and fatigued BIAD shareholders, I am no longer willing to remain passive.

I believe Bio-AMD is worth many multiples of the current valuation and that it is time for management and the Board to urgently pursue activities that are directly focused on increasing shareholder value. I have made numerous suggestions in the past: distribute monthly or bimonthly communications to investors, provide quarterly press releases and conference calls as a complement to the SEC filings, conduct insider purchases as a show of confidence or initiate a stock buyback policy. Furthermore, I've encouraged you to expand your Board of Directors to include individuals with experience in creating shareholder value in the microcap stock market and offered to make introductions to investment banking firms who could assist the company with completing a reverse split and uplisting BIAD shares to a senior exchange such as the NASDAQ.


Unfortunately, none of these suggestions have been acted upon, and the insular Board of Directors, which consists solely of three Officers of the company who each collect over $100,000/year, appears unable and/or unwilling to address even the most basic shareholder concerns.

I would like to speak with you and your colleagues, at your earliest convenience, about adding shareholder representation to the Board of Directors. Additionally, I would like to see the company retain a firm or individuals with expertise in helping quality, under-followed microcap companies like ours communicate with the investment community. Bio-AMD has a compelling story that very few people know about because no one, including executive management and the current Board, is actively sharing it! Finally, it may make sense to explore hiring an investment banker to review strategic alternatives for the company.

Thank you for your prompt attention to this letter.

Sincerely,

/s/ Benjamin L. Padnos
Benjamin L. Padnos
221 34th Street
Manhattan Beach, CA 90266

[JJSeabrook]

Be nice to hear something before EOY.

[croptop]

bid .07, getting close to the .05

[croptop]

No deal comes soon, I will use as for tax loss also...mid dec. or so...always buy back at .05 eh?

[PatrickBateman]

Like watching paint dry

[croptop]

Haha right, up 2 cents on a 100 volume and .01 on 66K volume
Real steady...many were trying to get at .10, well, i got a few, and next will wait for .05...As soon as I fill, it goes to .08 !!!

[jaytea]

Prepare for liftoff!

[croptop]

Market knows...

[derkampfer]

$3M market cap is ridiculously low for a company developing the technology it is (and doing it well). Unbelievable price back at $.08. Nonsense.

[croptop]

biad moves 2 cents on 100 share volume and .005 on 5000
ROFLOL

[croptop]

got a few more at .10.....probably a mistake, LOL